Contingent negative variation as a dopaminergic biomarker: evidence from dose-related effects of methylphenidate

Abstract

These results indicate that dopamine availability increases response readiness as measured by the CNV paradigm. The CNV appears to be a good candidate biomarker for assessing changes in dopaminergic function by treatments that either directly or indirectly target the dopaminergic system.